H20 Venture Partners
Venture studioOxford · Pre-Seed–Series A · 2 people tracked
Investment thesis
H2O focuses on social enterprises that combine commercial discipline with long-term impact in developing agricultural value chains. Rather than only investing in existing companies, the firm systematically creates new enterprises from scratch to address persistent failures across input manufacture, supply, post-harvest handling, and value-add processing. It targets a largely vacant commercial space it calls 'agricultural investment 2.0,' building scalable business models that align impact and commerciality, deploy significant capital, and recruit skilled management. H2O retains strategic control over a balanced portfolio of synergistic enterprises designed to address multiple value-chain failures simultaneously.
Source: firm website, verified Aug 7, 2026.
Team · 2 people
from public directories
What they invest in
from 6 of 21 portfolio companiesAgTech ×3Biotech ×2Consumer ×2FoodTech ×2AI & Machine Learning ×1Direct to Consumer ×1E-commerce ×1Healthtech ×1
HQs:Rwanda×3Tanzania×1
Investments · 21 tracked
founders shown can be your intro pathDeveloped a sensitive method for amplifying point mutations in cell-free DNA for early cancer diagnosis; acquired by EKF Diagnostics in 2013.
Network of instrumented bird boxes using citizen science to study the effects of habitat and climate change on wild vertebrates.
EKF Diagnostics develops and manufactures point-of-care in-vitro diagnostic (IVD) medical devices and tests, along with reagents, enzymes, and central-laboratory analysis tools for healthcare providers, clinicians, and researchers.
BiotechHealthtechMedical Devices
Rwandan beans processor exporting across East Africa, raising smallholder incomes and reducing firewood use and CO2 emissions.
Applies stereo photogrammetry for 3D imaging across sectors, including healthcare applications; spun out of Oxford University as Eykona in 2008.
Markets Virunga Forest honey to raise smallholder incomes and reduce economic exploitation of Mountain Gorilla habitat.
Ingabo supplies agricultural inputs including insecticides, fungicides, fertilizers, seed coatings, animal products, and water purification tablets.
AgTech
Supplies critical pest and disease control inputs to Rwandan smallholders via a direct-from-manufacturer model.
Commercialised a biological process for treating oily waste waters; spun out of Oxford in 2007 and acquired by BP in 2014.
Milele designs and sells premium iPhone cases, including oil-waxed and pebble-texture leather models and MagSafe-compatible silicone cases, for the latest iPhone lineup.
ConsumerDirect to ConsumerE-commerce
Flyttr operates a biosecurity platform that develops and deploys countermeasures against pest threats, combining autonomous pest monitoring systems, AI-powered decision-support, and biological interventions such as engineered Aedes aegypti and Wolbachia.
AgTechAI & Machine LearningBiotech
Works with smallholder cooperatives to multiply and distribute high-yielding maize seed varieties in Rwanda.
Cleans, aggregates and trades beans and maize from Rwandan smallholders using a warrantage system.
Early-stage Rwandan enterprise developing WASH and nutrition products distributed via Community Health Workers.
Developed a retinal imaging device for low-cost glaucoma diagnosis; spun out of City, University of London in 2014 (currently dormant).
Develops and markets low-cost, labour-saving agricultural tools for smallholders (currently dormant).
Exits · 3
IPOs and acquisitions across the tracked portfolio360 Genomicsacq. by EKF DiagnosticsMicrobial Solutionsacq. by bpOxitecacq. by Precigen
Frequently asked questions
- What stage does H20 Venture Partners invest at?
- H20 Venture Partners invests at the Pre-Seed, Seed, Series A stages.
- What sectors does H20 Venture Partners focus on?
- H20 Venture Partners focuses on AgTech, Biotech, Cleantech, Climate Tech, Healthtech, Impact & Social Good, Medical Devices.
- Where is H20 Venture Partners located?
- H20 Venture Partners is headquartered in Oxford, GB.
Similar investors
Future Positive Capital's portfolio page showcasing companies across health, climate, and deeptech sectors.
Innovestor is a Nordic investment group operating across venture capital, life science, real estate, energy storage, and corporate venturing platforms, and is among the most active early-stage investors in the region.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.